Table 1.
Clinical data
| Case | Age (y)/ sex | Histology | Treatment | RT dose (Gy)/fractions | Rec/met (mo) | Follow-up (mo) |
|---|---|---|---|---|---|---|
| 1 | 58/F | Intimal sarcoma | R2, adj RT | 59.4/33 | - / + (3) | Died (13) |
| 2 | 20/M | Angiosarcoma | R0, adj RT, CT | 59.4/33 | + / + (20) | Alive (20) |
| 3 | 34/M | Intimal sarcoma | Rx, adj RT | 66.0/37 | - / + (x) | Died (84) |
| 4 | 60/F | Angiosarcoma | RT | 60.0/30 | - / + (12) | Died (24) |
| 5 | 65/F | Synovial sarcoma | Rx, adj RT | 59.4/33 | + / + (12) | Died (24) |
| 6 | 57/M | Intimal sarcoma | R0, adj RT | 59.4/33 | + / + (35) | Died (45) |
| 7 | 61/F | Angiosarcoma | R1, adj RT | 54.0/30 | - / - | NED (12) |
| 8 | 17/M | Angiosarcoma | R0, CTa | 60.0/30b | + / - (48) | NED (86) |
F female, M male, y years, R resection status, adj adjuvant, RT radiotherapy, CT chemotherapy, Rec/met recurrence/metastases, mo months, NED no evidence of disease
a adjuvant adriamycin and ifosfamide
b patient developed a local recurrence 4 years after initial diagnosis which was treated by resection and adjuvant radiotherapy